These were the biggest pharmaceutical deals in early 2022

GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector.

COVID-19 treatment Paxlovid has been free so far. Next year, sticker shock awaits

Pfizer - Wikipedia

The top 10 biopharma M&A deals of 2022

Biopharma M&A: Year in Review, Ripples Ahead

Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology

2023 Pharm Exec Top 50 Companies

Pipelinepharma

These were the biggest pharmaceutical deals in early 2022 - Pharmaceutical Technology

U.S. new drug price exceeds $200,000 median in 2022

Biopharma M&A: Year in Review, Ripples Ahead

2022 turns out to be another unspectacular year for pharma and biotech

The biggest-selling pharma companies of 2023

With $1.7T in the coffers, biopharma M&A expected to be 'a different animal' in 2022

Top Pharma Companies & Drugs in 2022: Pfizer breaks US$ 100 bn barrier, AbbVie's Humira retains 2nd spot

Pollution and health: a progress update - The Lancet Planetary Health